The drug lovastatzin, developed from their work, is widely used to reduce the threat of heart attacks in patients with high cholesterol levels.

On the other hand, studies show that vitamin E may reduce heart problems in high-risk patients such as certain diabetics.

Aspirin (and sometimes clopidogrel) may reduce the chance of a heart attack in certain patients.

The initial and maintenance doses should be reduced in patients with severe liver disease.

It is mainly used to reduce cholesterol levels in patients at risk of cardiovascular disease.

Pseudocholinesterase levels may be reduced in patients with advanced liver disease.

Less aggressive treatment may sometimes reduce the risk of injury, particularly in patients who have a good chance of getting well again.

It was also shown to reduce the severity of the disease in patients who developed polio.

It can also reduce the need for transfusions in patients undergoing heart bypass surgery.

It has been shown to reduce the need for blood transfusion in patients with significant hemolysis.